Tokyo, Japan

Yoshiki Goda

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Ea Pharma Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiki Goda. Retrieved from https://idiyas.com/inventor/yoshiki-goda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshiki Goda

Introduction

Yoshiki Goda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ulcerative colitis. His innovative approach has led to the development of a unique pharmaceutical composition that addresses this challenging condition.

Latest Patents

Yoshiki Goda holds a patent for a pharmaceutical composition aimed at treating ulcerative colitis. This composition comprises a compound represented by a specific formula or a pharmaceutically acceptable salt thereof. The key aspect of this invention is that the compound or its salt is administered in an amount of 600 mg or more per day to patients suffering from ulcerative colitis. This patent highlights his commitment to improving patient outcomes through innovative medical solutions. He has 1 patent to his name.

Career Highlights

Yoshiki Goda is associated with Ea Pharma Co., Ltd., where he continues to work on advancing pharmaceutical research and development. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking medical advancements.

Collaborations

Some of his notable coworkers include Shunsuke Kageyama and Toshihiko Sugiura. Their collective expertise fosters a collaborative environment that enhances the potential for innovative breakthroughs in pharmaceutical science.

Conclusion

Yoshiki Goda's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the treatment of ulcerative colitis, demonstrate the impact that dedicated inventors can have on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…